Neoadj T-VEC May Improve Survival in Resectable Melanoma

Offering talimogene laherparepvec before surgery compared with surgery alone could improve event-free as well as overall survival in patients with advanced resectable melanoma, a new analysis suggests.

Related Keywords

Zurich ,Züsz ,Switzerland ,Reinhard Dummer ,Pierre Fabre ,Amgen ,Novartis ,University Hospital Of Zurich ,Department Of Dermatology ,Bristol Myers Squibb ,University Hospital ,Merck Sharp ,Melanoma ,Malignant Melanoma ,Skin Cancer ,Alignant Skin Neoplasm ,Surgery ,Neoadjuvant ,Adjuvant Therapy ,Biologic Therapy ,Iologics ,